Alnylam Pharmace. sell Biotechhunter
Start price
24.08.20
/
50%
€111.76
Target price
28.08.20
-
Performance (%)
-0.47%
End price
28.08.20
€111.24
Summary
This prediction ended on 28.08.20 with a price of €111.24. From the start of the prediction for Alnylam Pharmace. the price only changed by -0.47%. Biotechhunter has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Alnylam Pharmace. | -9.609% | -9.609% | -10.847% | 40.728% |
| iShares Core DAX® | -1,09 % | 0,20 % | 2,09 % | 52,05 % |
| iShares Nasdaq 100 | -2,46 % | -1,79 % | 29,25 % | 84,79 % |
| iShares Nikkei 225® | -5,37 % | -5,43 % | 54,33 % | 69,71 % |
| iShares S&P 500 | -0,20 % | 1,77 % | 23,58 % | 69,52 % |
Comments by Biotechhunter for this prediction
In the thread Alnylam Pharmace. diskutieren
Sell Alnylam Pharmace.